Walgreens Donates Funds to Support the CDC Foundation’s Sustainable Healthcenter Implementation PrEP Pilot

Following last year’s impactful collaboration between Walgreens and the CDC Foundation addressing the Zika outbreak, the two organizations are once again working together to help address another public health challenge—HIV prevention. To help extend the CDC Foundation’s important research and demonstration project, Walgreens made a donation today to help fund the CDC Foundation’s Sustainable Healthcenter Implementation PrEP Pilot (SHIPP) study.

Global Cryptococcal Meningitis Screening

950
global health
Global Cryptococcal Meningitis Screening
Botswana
To determine feasibility and cost of prevention of Cryptococcal disease in African, Asian and Central American countries via the implementation of a “screen-and-treat” strategy. This strategy will support and guide policy makers in the rollout and sustained management of a successful “screen-and-treat” program. This project is expanding to an additional 8-12 countries.
Pfizer Inc.
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Clinical Trials Unit for HIV/AIDS and TB Research

788
Thailand couple
Clinical Trials Unit for HIV/AIDS and TB Research
Bangkok, Thailand
Thailand
To facilitate formation of a Clinical Trials Unit for HIV/AIDS and tuberculosis research to advance therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.
Emory University (National Institutes of Health)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

Teens Linked to Care

900
teenagers
Teens Linked to Care
Indiana, Kentucky, Ohio, USA
United States of America
To provide substance use and HIV prevention education, access to health services, safe and supportive environments and monitoring and evaluation for high-risk communities in Kentucky, Ohio and Indiana.
Conrad Hilton Foundation
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

Study of Dapivirine Gel Administered Rectally

911
holding hands
Study of Dapivirine Gel Administered Rectally
Thailand
To study the effectiveness of dapivirine gel exposure intended to prevent HIV transmission.
Magee-Womens Research Institute and Foundation (National Institutes of Health/National Institute of Allergy and Infectious Disease)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health

Preventing Mother-to-Child Transmission of HIV and HBV

679
pregnant woman
Preventing Mother-to-Child Transmission of HIV and
China
To help CDC increase understanding of the effectiveness of using maternal tenofovir containing combination drug during the second and third trimesters of pregnancy for the prevention of mother-to-child transmission of HIV and HBV in co-infected mothers.
Gilead Sciences, Inc.
CDC's National Center for Chronic Disease Prevention and Health Promotion

AIDS and Kaposi’s Sarcoma in Uganda

888
Boy
AIDS and Kaposi’s Sarcoma in Uganda
Uganda
To perform Human Herpesvirus-8 (HHV-8) diagnostics on specimens from a UCSF study on antiretroviral therapy for patients with AIDS and Kaposi’s sarcoma in Uganda.
University of California San Francisco
CDC’s National Center for Immunization and Respiratory Diseases

Combination HIV Prevention Intervention in Thailand

914
thailand
Combination HIV Prevention Intervention in Thailan
Thailand
To conduct a study to assess the feasibility of a combination HIV preventive intervention with and without daily Truvada PrEP for HIV uninfected young men who have sex with men in Bangkok, Thailand.
Johns Hopkins University (National Institutes of Health/National Institute of Allergy and Infectious Disease)
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health
Subscribe to HIV